FdaApplication
BLA 021017
Identifiers
- fda_app_no: BLA021017
Properties
| Property | Value |
|---|---|
| applicant_name | Eli Lilly and Company |
| application_type | BLA |
| approval_date | 1999-12-22 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| HUMALOG MIX 75/25 | INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT | 750UNITS/10ML (75UNITS/ML); 250UNITS/10ML (25UNITS/ML) | Injectable Suspension |
| HUMALOG MIX 75/25 | INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT | 225UNITS/3ML (75UNITS/ML); 75UNITS/3ML (25UNITS/ML) | Injectable Suspension |
| HUMALOG MIX 75/25 | INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT | 225UNITS/3ML (75UNITS/ML); 75UNITS/3ML (25UNITS/ML) | Injectable Suspension |
3 products